Targeting the microRNA-34a as a Novel Therapeutic Strategy for Cardiovascular Diseases

Cardiovascular diseases (CVDs) are still the main cause of morbidity and mortality worldwide and include a group of disorders varying from vasculature, myocardium, arrhythmias and cardiac development. MicroRNAs (miRs) are endogenous non-coding RNAs with 18–23 nucleotides that regulate gene expressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Hua, Cun-Cun, Liu, Xin-Ming, Liang, Li-Rong, Wang, Le-Feng, Zhong, Jiu-Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828972/
https://www.ncbi.nlm.nih.gov/pubmed/35155600
http://dx.doi.org/10.3389/fcvm.2021.784044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828972/
https://www.ncbi.nlm.nih.gov/pubmed/35155600
http://dx.doi.org/10.3389/fcvm.2021.784044

Ejemplares similares